A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

Clinical trial NCT07407933 · RECRUITING

Trial details

NCT number: NCT07407933
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma

Start date: 2026-03-31
Primary completion: 2028-11-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.